We look forward to meeting with you at ASCO 2023!

The Clinical Real-world Data and AI Leader

Schedule a meeting in advance or request a demo at booth #4049 for any of our products and services.

The Clinical Real-world Data and AI Leader

Meet With Us

ConcertAI 2023 ASCO Posters

Meet at ASCO 2023

Enhancement in Line of Therapy (LoT) derivation from real-world data (RWD) from Electronic Health Records (EHR) via integration of medical claims data

Abstract: 6514 | Poster Bd #: 6

Authors:

Smita Agrawal, Avinash P B, Rohini George, Neeraj Singh, Megha Soni, Sangavai Chakkrapani, Vandana Priya, Vivek Vaidya

Organizations:

ConcertAI
Learn More

Development of Natural Language Processing (NLP) models for extracting key features from unstructured notes to create real-world data (RWD) assets for clinical research at scale

Abstract: 6607 | Poster Bd #: 99

Authors

Smita Agrawal, Rohini George, Vivek Vaidya, Sangavai Chakkrapani, Rambaksh Prajapati, Srikanth Tankala, Dhaval Parmar, Vinay Phani Santosh Lakkimsetty, Tapasya Bhardwaj, Ashwani Ashwani, Emma Mendonca, Babu Narayanan, Krishna Kumar Swaminathan, Pranay Mukherjee

Organizations

ConcertAI, Syneos Health, Merck & Co., Inc., Self

Learn More

Site of metastasis (SoM) and its impact on clinical outcomes in 8 cancer cohorts

Abstract: 6590 | Poster Bd #: 82

Authors

Rohini George, Neeraj Singh, Laura Vidal, Ewa Hajek, Dorota Skalska, Kamal Saini, Smita Agrawal

Organizations

ConcertAI, Labcorp Drug Development, Labcorp, Labcorp Oncology

Learn More

Assessment of Electronic Health Record (EHR)-based Machine learning (ML) in Predicting Risk of Brain Metastasis among Patients with Early-stage Non-small Cell Lung Cancer (eNSCLC)

Abstract: 2036 | Poster Bd #: 393

Authors

Hossein Honarvar, Deep Hathi, Ravi Parikh, Rahul Das

Organizations

ConcertAI, Perelman School of Medicine, University of Pennsylvania

Learn More

Electronic Health Record (EHR)-based Machine learning (ML) to Predict Disease Recurrence after Surgical Resection of Early-stage Non-Small Cell Lung Cancer (eNSCLC)

Abstract: 6626 | Poster Bd #: 118

Authors

Steven Pisano, Hossein Honarvar, Ravi Parikh, Rahul Das

Organizations

ConcertAI, Perelman School of Medicine, University of Pennsylvania

Learn More

Association between severe adverse event management and overall survival in immune checkpoint inhibitor-treated patients with advanced non-small cell lung cancer

Abstract: 6604 | Poster Bd #: 96

Authors

Jarushka Naidoo, Douglas Johnson, Charlotte Doran, Yuexi Wang, Yan Zhang, Trong Le, Sari Hopson, Brian Dreyfus, Lincy Lal, Charmy Vyas, Shay Goldstein, Zara Izadi

Organizations

Beaumont RCSI Cancer Center, Vanderbilt University Medical Center, ConcertAI, Bristol Myers Squibb, Bristol-Myers Squibb

Learn More

Real-world Response Endpoints in Patients With mNSCLC Treated with Chemotherapy Across Real-world Datasets

Abstract: 6595 | Poster Bd #: 87

Authors

Brittany McKelvey, Elizabeth Garrett-Mayer, Andrew Belli, Thomas Brown, Jessica Dow, Janet Espirito, Paul Kluetz, Xinran Ma, Andrea McCracken, Pallavi Mishra-Kalyani, Yanina Natanzon, Danielle Potter, Donna Rivera, Hillary Stires, Mark Stewart, Jeff Allen

Organizations

Friends of Cancer Research, American Society of Clinical Oncology, COTA Inc, Syapse, Tempus Labs, Inc., Ontada, Oncology Center of Excellence, U.S. Food and Drug Administration, Flatiron Health, Guardian Research Network, US Food and Drug Administration, ConcertAI, IQVIA, Oncology Center of Excellence, Office of the Commissioner, U.S. Food and Drug Administration

Learn More
ConcertAI CEO | Jeff Elton

Why We Attend ASCO

 

Read Our Blog from ASCO 2022

Read Our Blog from ASCO 2022